TRACON Pharmaceuticals Inc (NASDAQ:TCON)

1.51
Delayed Data
As of Nov 23
 0.00 / 0.00%
Today’s Change
1.24
Today|||52-Week Range
3.79
-45.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues7.9M3.4M8.8M3.0M
 
 
 
 
 
Depreciation And Amortization51.0K94.0K48.0K28.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses31.3M29.3M26.9M37.7M
 
 
 
 
 
Research And Development25.7M21.6M19.4M30.5M
 
 
 
 
 
Total Operating Expenses31.4M29.4M27.0M37.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.5M-26.0M-18.2M-34.7M
 
 
 
 
 
Extraordinary Charge-65.0K0.000.000.00
 
 
Interest Expense On Debt923.0K1.1M886.0K231.0K
 
 
 
 
 
Other Expenses45.0K87.0K-7.0K12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.4M-27.0M-19.1M-35.0M
 
 
 
 
 
Net Income-24.4M-27.0M-19.1M-35.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.1M12.7M16.8M26.9M
 
 
 
 
 
Shares To Calculate EPS Diluted11.1M12.7M16.8M26.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.20-$2.13-$1.14-$1.30
 
 
 
 
 
EPS Diluted-$2.20-$2.13-$1.14-$1.30